Evidence map›Paper›PMID 38252849›Full record

ArticleDiabetes care2024

Clinical Prediction Models Combining Routine Clinical Measures Have High Accuracy in Identifying Youth-Onset Type 2 Diabetes Defined by Maintained Endogenous Insulin Secretion: The SEARCH for Diabetes in Youth Study.

Angus G Jones, Beverley M Shields, Richard A Oram, Dana M Dabelea, William A Hagopian, Seth A Sharp, Eva Lustigova, Amy S Shah, Julieanne Knupp, Amy K Mottl and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes care, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 10 institutions in 2 countries.

Angus G JonesUniversity of Exeter Medical School, Exeter, U.K.ORCID 0000-0002-0883-7599
Beverley M ShieldsUniversity of Exeter Medical School, Exeter, U.K.
Richard A OramUniversity of Exeter Medical School, Exeter, U.K.
Dana M DabeleaUniversity of Colorado Anschutz Medical Campus, Aurora, CO.
William A HagopianUniversity of Washington, Seattle, WA.
Seth A SharpDepartment of Genetics, Stanford University School of Medicine, Stanford, CA.
Eva LustigovaKaiser Permanente Southern California, Los Angeles, CA.
Amy S ShahUniversity of Cincinnati and Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Julieanne KnuppUniversity of Exeter Medical School, Exeter, U.K.
Amy K MottlUniversity of North Carolina at Chapel Hill, Chapel Hill, NC.
Ralph B D'AgostinoWake Forest School of Medicine, Winston-Salem, NC.
Adrienne WilliamsWake Forest School of Medicine, Winston-Salem, NC.
Santica M MarcovinaMedpace Reference Laboratories, Cincinnati, OH.
Catherine PihokerUniversity of Washington, Seattle, WA.
Jasmin DiversWake Forest School of Medicine, Winston-Salem, NC.
Maria J RedondoBaylor College of Medicine and Texas Children's Hospital, Houston, TX.
University of Exeter · GBCincinnati Children's Hospital Medical Center · USMedpace (United States) · USUniversity of North Carolina at Chapel Hill · USUniversity of Washington · USBaylor College of Medicine · USKaiser Permanente · USTexas Children's Hospital · USUniversity of Colorado Anschutz Medical Campus · USWake Forest University · US

Funding

Institute of Translational Health SciencesUL1TR000423 · NCATS · UNIVERSITY OF WASHINGTON · PI DISIS, MARY L. · 2012 to 2016
$49.4M
South Carolina Clinical & Translational Research Institute (SCTR)UL1TR001450 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T., FLUME, PATRICK A · 2015 to 2024
$41.1M
LCenter for Clinical and Translational Science and TrainingUL1TR001425 · NCATS · UNIVERSITY OF CINCINNATI · PI HEUBI, JAMES E., KISSELA, BRETT M · 2015 to 2024
$37.5M
Colorado Clinical and Translational Science Institute (UL1)UL1TR000154 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2012 to 2013
$20.4M
Limited Competition for the Continuation of the SEARCH for Diabetes in Youth Cohort Study (UC4)SEARCH for Diabetes in Youth Cohort StudyUC4DK108173 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI DAGOSTINO, RALPH B. · 2015 to 2016
$14.8M
UCHSC DIABETES ENDOCRINOLOGY RESEARCH CENTERP30DK057516 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI HUTTON, JOHN C · 2000 to 2010
$14.0M
Cincinnati Center for Clinical and Translational Sciences and TrainingUL1TR000077 · NCATS · UNIVERSITY OF CINCINNATI · PI HEUBI, JAMES E., TSEVAT, JOEL · 2012 to 2014
$9.9M
South Carolina Clinical & Translational Research Institute (SCTR)UL1TR000062 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T. · 2012 to 2014
$9.4M
SEARCH for Diabetes in Youth 2: Colorado CenterU01DP000247 · DP · UNIVERSITY OF COLORADO DENVER · PI DABELEA, DANA · 2005 to 2009
$3.6M
SEARCH for Diabetes in Youth 2: South Carolina CenterU01DP000254 · DP · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MAYER-DAVIS, ELIZABETH J · 2005 to 2009
$3.5M
SEARCH for Diabetes in Youth 2: Washington SiteU01DP000244 · DP · SEATTLE CHILDREN'S HOSPITAL · PI PIHOKER, CATHERINE · 2005 to 2009
$2.7M
Type 1 diabetes genetic risk scores for the diagnosis of diabetes type in children of diverse racial and ethnic backgroundR01DK124395 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI REDONDO, MARIA JOSE · 2021 to 2024
$2.6M
Barbara Davis Center at the University of Colorado at DenverCare Research Exeter Biomedical Research CentreCDC HHS 00097Cincinnati Children's Hospital Medical Center 1U18DP002709Clinical and Translational Research Institute at the Medical University of South CarolinaDiabetes and Endocrinology Research CenterDiabetes UK 16/0005529EPA EP-C-15-002HSRD VA HIR 10-001Kaiser Foundation Health PlanKaiser Permanente Southern CaliforniaMarilyn Owsley Clinical Research CenterNational Institute for HealthNCATS NIH HHS UL1 TR000062NCATS NIH HHS UL1 TR000077NCATS NIH HHS UL1 TR000154NCATS NIH HHS UL1 TR000423NCATS NIH HHS UL1 TR001425NCATS NIH HHS UL1 TR001450NCCDPHP CDC HHS U01 DP000244NCCDPHP CDC HHS U01 DP000246NCCDPHP CDC HHS U01 DP000247NCCDPHP CDC HHS U01 DP000248NCCDPHP CDC HHS U01 DP000250NCCDPHP CDC HHS U01 DP000254NCCDPHP CDC HHS U18 DP002708NCCDPHP CDC HHS U18 DP002709NCCDPHP CDC HHS U18 DP002710NCCDPHP CDC HHS U18 DP002714NCCDPHP CDC HHS U18 DP006131NCCDPHP CDC HHS U18 DP006133NCCDPHP CDC HHS U18 DP006134NCCDPHP CDC HHS U18 DP006136NCCDPHP CDC HHS U18 DP006138NCCDPHP CDC HHS U18 DP006139NIDDKNIDDK NIH HHS P30 DK057516NIDDK NIH HHS R01 DK124395NIDDK NIH HHS R01 DK127208NIDDK NIH HHS UC4 DK108173NIH HHS P30 DK57516NIH NIDDK 1R01DK127208-01NIHRSouthern California Permanente Medical GroupUniversity of Washington UL1 TR00423Wake Forest University School of Medicine 200-2010-35171
6 · The paper itself

Abstract

objectiveWith high prevalence of obesity and overlapping features between diabetes subtypes, accurately classifying youth-onset diabetes can be challenging. We aimed to develop prediction models that, using characteristics available at diabetes diagnosis, can identify youth who will retain endogenous insulin secretion at levels consistent with type 2 diabetes (T2D). RESEARCH DESIGN AND

methodsWe studied 2,966 youth with diabetes in the prospective SEARCH for Diabetes in Youth study (diagnosis age ≤19 years) to develop prediction models to identify participants with fasting C-peptide ≥250 pmol/L (≥0.75 ng/mL) after >3 years' (median 74 months) diabetes duration. Models included clinical measures at the baseline visit, at a mean diabetes duration of 11 months (age, BMI, sex, waist circumference, HDL cholesterol), with and without islet autoantibodies (GADA, IA-2A) and a type 1 diabetes genetic risk score (T1DGRS).

resultsModels using routine clinical measures with or without autoantibodies and T1DGRS were highly accurate in identifying participants with C-peptide ≥0.75 ng/mL (17% of participants; 2.3% and 53% of those with and without positive autoantibodies) (area under the receiver operating characteristic curve [AUCROC] 0.95-0.98). In internal validation, optimism was very low, with excellent calibration (slope 0.995-0.999). Models retained high performance for predicting retained C-peptide in older youth with obesity (AUCROC 0.88-0.96) and in subgroups defined by self-reported race and ethnicity (AUCROC 0.88-0.97), autoantibody status (AUCROC 0.87-0.96), and clinically diagnosed diabetes types (AUCROC 0.81-0.92).

conclusionsPrediction models combining routine clinical measures at diabetes diagnosis, with or without islet autoantibodies or T1DGRS, can accurately identify youth with diabetes who maintain endogenous insulin secretion in the range associated with T2D.

Indexed as

Diabetes Mellitus, Type 2Insulin SecretionAdolescentChildC-PeptideFemaleHumansInsulinMaleProspective StudiesYoung AdultC-PeptideInsulin

Identifiers

PMID38252849
PMCPMC11655402
OpenAlexW4391092229

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.